Physician profile
Susan Doyle
NPI 1740248665
$2,850.28
in general payments reported to CMS, 2019-2025
27 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $267 · 2021: $238 · 2022: $706 · 2023: $598 · 2024: $231 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,134 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,133.59 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $652.87 | 2019-2025 | Acessa Provu System, Myosure Tissue Removal Device, Aptima |
| Aspira Women'S Health INC | $565.28 | 2022-2023 | Ova1 |
| Abbvie INC. | $266.60 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $232.05 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $173.62 | 2022-2025 | |
| Organon LLC | $121.65 | 2021-2025 | Nexplanon, Jada System |
| Channel Medsystems, INC. | $120.77 | 2023 | |
| Therapeuticsmd, INC. | $82.78 | 2019-2022 | |
| Millicent US INC | $76.35 | 2024-2025 | Intrarosa, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $76.09 | 2021-2023 | |
| Exeltis, USA INC. | $72.59 | 2019-2025 | Slynd |
| Sumitomo Pharma America, INC. | $54.22 | 2025 | Myfembree |
| Lupin INC. | $46.88 | 2019 | |
| Agile Therapeutics, INC. | $39.68 | 2023 | Twirla |
| Coopersurgical, INC. | $38.50 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $31.35 | 2022 | |
| Gynesonics, INC. | $24.68 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Merck Sharp & Dohme LLC | $24.29 | 2019-2020 | |
| Evofem Biosciences, INC. | $23.66 | 2022 | |
| Minerva Surgical, INC | $23.28 | 2019-2022 | |
| Ethicon US, LLC | $23.15 | 2019 | |
| Optumhealth Care Solutions, LLC | $15.21 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Pfizer INC. | $14.91 | 2023 | |
| Duchesnay USA Incorporated | $13.56 | 2019 | |
| Allergan, INC. | $13.36 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.21 | 2019 | |
| Meditrina | $10.69 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Doyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.